Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
Introduction Patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations (ExCOPD) are commonly treated with inhaled corticosteroids (ICS) and are at risk of infections caused by potential pathogenic bacteria (PPB) including Pseudomonas aeruginosa (PsA).Objectives To invest...
Saved in:
| Main Authors: | Antonio Oliver, Borja G Cosío, Hanaa Shafiek, Javier Verdú, Amanda Iglesias, Lluisa Ramon-Clar, Nuria Toledo-Pons, Carla Lopez-Causape, Carlos Juan, Pablo Fraile-Ribot |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-01-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/8/1/e001067.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corticosteroids modulate biofilm formation and virulence of Pseudomonas aeruginosa
by: Elena Jordana-Lluch, et al.
Published: (2025-06-01) -
Minimising inhaled corticosteroids for COPD
by: Benji Heran, et al.
Published: (2024-12-01) -
Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment
by: Lucie Blais, et al.
Published: (2004-01-01) -
Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.
by: Patrick White, et al.
Published: (2013-01-01) -
Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria
by: Guergana Petrova, et al.
Published: (2016-11-01)